Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions

Overview

The objective of this protocol is to enable collection of biospecimens to facilitate current and future multidisciplinary research in rare genetic disorders and medical conditions.

Study Type

  • Study Type: Observational
  • Study Design

Clinical Trial Outcome Measures

Primary Measures

  • continuous collection of donated study subject samples
    • Time Frame: unknown, continuous sample collection

Participating in This Clinical Trial

Inclusion Criteria

  • Willing and able to provide written, signed informed consent – Willing and able to comply with all study procedures Exclusion Criteria:

  • Use of any investigational product or investigational medical device within 30 days prior to screening, except as part of a BioMarin-sponsored study – Concurrent disease or condition that would interfere with study participation or safety.

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • BioMarin Pharmaceutical
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Evelyn Wang, 415-506-6818, EWang@bmrn.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.